ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,433.76
0.63%
Dow Jones
39,512.84
0.32%
Gold vs US Dollar
2,360.48
0.00%
Brent Oil
82.585
0.00%
Bitcoin
61,200.28
0.67%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE
  6. Allergy Therapeutics Plc (AGY)

  7. Allergy Therapeutics Plc (AGY) News

Allergy Therapeutics (AGY)

Allergy Therapeutics Plc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:AGY
DateTimeSourceHeadlineSymbolCompany
07/05/202420:22Alliance NewsAlliance NewsTRADING UPDATES: Abingdon Health buys IVDeology HoldingsLSE:AGYAllergy Therapeutics Plc
07/05/202407:00RNS Regulatory NewsAllergy Therapeutics PLC Further detail from G306 Phase III field trialLSE:AGYAllergy Therapeutics Plc
03/04/202407:00RNS Regulatory NewsAllergy Therapeutics PLC Director ResignationLSE:AGYAllergy Therapeutics Plc
27/03/202416:13Alliance NewsAlliance NewsEARNINGS AND TRADING: Solid State ups outlook; Quartix trading in lineLSE:AGYAllergy Therapeutics Plc
27/03/202407:00RNS Regulatory NewsAllergy Therapeutics PLC Interim Results for six months ended 31 Dec 2023LSE:AGYAllergy Therapeutics Plc
27/03/202407:00RNS Regulatory NewsAllergy Therapeutics PLC Update on fundingLSE:AGYAllergy Therapeutics Plc
12/03/202414:06Alliance NewsAlliance NewsAllergy Therapeutics starts dosing patients in peanut allergy trialLSE:AGYAllergy Therapeutics Plc
12/03/202408:59RNS Regulatory NewsAllergy Therapeutics PLC VLP Peanut PROTECT Trial UpdateLSE:AGYAllergy Therapeutics Plc
12/03/202407:00RNS Non-RegulatoryAllergy Therapeutics PLC VLP Peanut PROTECT Trial UpdateLSE:AGYAllergy Therapeutics Plc
11/03/202407:00RNS Regulatory NewsAllergy Therapeutics PLC Appointment of Shaun Furlong to Board of DirectorsLSE:AGYAllergy Therapeutics Plc
08/03/202413:49RNS Regulatory NewsAllergy Therapeutics PLC Result of AGMLSE:AGYAllergy Therapeutics Plc
14/02/202410:22Alliance NewsAlliance NewsAllergy Therapeutics forecasts revenue drop but trials going wellLSE:AGYAllergy Therapeutics Plc
14/02/202407:00RNS Regulatory NewsAllergy Therapeutics PLC Half-Year Trading Update 2024LSE:AGYAllergy Therapeutics Plc
09/02/202415:07RNS Regulatory NewsAllergy Therapeutics PLC Notice of 2023 Annual General MeetingLSE:AGYAllergy Therapeutics Plc
30/01/202410:38Alliance NewsAlliance NewsAllergy Therapeutics resumes trading on AIM; annual revenue plungesLSE:AGYAllergy Therapeutics Plc
30/01/202407:30RNS Regulatory NewsAIM Restoration - Allergy Therapeutics plcLSE:AGYAllergy Therapeutics Plc
30/01/202407:00RNS Regulatory NewsAllergy Therapeutics PLC Publication of Annual Report and Accounts 2023LSE:AGYAllergy Therapeutics Plc
04/01/202412:29UK RegulatoryAllergy Therapeutics PLC Total Voting RightsLSE:AGYAllergy Therapeutics Plc
02/01/202407:30UK RegulatoryAIM Suspension - Allergy Therapeutics plcLSE:AGYAllergy Therapeutics Plc
27/12/202314:17Alliance NewsAlliance NewsIN BRIEF: Allergy Therapeutics amends facility, plans warrant issueLSE:AGYAllergy Therapeutics Plc
27/12/202312:01UK RegulatoryAllergy Therapeutics PLC Amendment to existing Facility AgreementLSE:AGYAllergy Therapeutics Plc
15/12/202321:09Alliance NewsAlliance NewsEARNINGS AND TRADING: Redx full year revenue tumbles; loss widensLSE:AGYAllergy Therapeutics Plc
15/12/202312:48UK RegulatoryAllergy Therapeutics PLC Annual Report and Accounts DelayedLSE:AGYAllergy Therapeutics Plc
13/12/202316:54UK RegulatoryAllergy Therapeutics PLC PDMR dealing and Total Voting RightsLSE:AGYAllergy Therapeutics Plc
13/12/202310:11Alliance NewsAlliance NewsAllergy Therapeutics shares jump as hails grass allergy jab dataLSE:AGYAllergy Therapeutics Plc
13/12/202307:00UK RegulatoryAllergy Therapeutics PLC G306 Phase III trial meets key endpointsLSE:AGYAllergy Therapeutics Plc
11/12/202310:40Alliance NewsAlliance NewsIN BRIEF: Allergy Therapeutics stock falls on lower sales outlookLSE:AGYAllergy Therapeutics Plc
11/12/202307:00UK RegulatoryAllergy Therapeutics PLC Update on fundingLSE:AGYAllergy Therapeutics Plc
01/12/202307:00UK RegulatoryAllergy Therapeutics PLC Total Voting RightsLSE:AGYAllergy Therapeutics Plc
28/11/202315:03UK RegulatoryAllergy Therapeutics PLC Holding(s) in CompanyLSE:AGYAllergy Therapeutics Plc
 Showing the most relevant articles for your search:LSE:AGY

Your Recent History

LSE
PET
Petrel Resources
LSE
TERN
Tern
LSE
VAST
Vast Resources
LSE
GKP
Gulf Keystone Petroleum
LSE
POS
Plexus
LSE
SCLP
Scancell
LSE
SCE
Surface Transforms
LSE
OXB
Oxford Biomedica
LSE
AGL
Angle
LSE
SRSP
Sirius Petroleum
LSE
ITV
Itv
LSE
PANR
Pantheon Resources
LSE
GOLD
LSE
EEE
Empire Metals
LSE
ENET
Ethernity Networks
LSE
SYME
Supply@me Capital
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved